Lineage Cell Therapeutics (LCTX) Enterprise Value (QoQ) (2010 - 2026)
Lineage Cell Therapeutics (LCTX) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lineage Cell Therapeutics | 267.08 Mn | 203.18 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.80% |
| Dec 31, 2025 | -85.61% |
| Sep 30, 2025 | 23.12% |
| Jun 30, 2025 | 11.60% |
| Mar 31, 2025 | -10.98% |
| Dec 31, 2024 | -30.20% |
| Sep 30, 2024 | 14.57% |
| Jun 30, 2024 | 11.35% |
| Mar 31, 2024 | -43.50% |
| Dec 31, 2023 | 26.66% |
| Sep 30, 2023 | 9.60% |
| Jun 30, 2023 | 1.90% |
| Mar 31, 2023 | 18.61% |
| Dec 31, 2022 | 12.50% |
| Sep 30, 2022 | 7.67% |
| Jun 30, 2022 | 9.71% |
| Mar 31, 2022 | -36.18% |
| Dec 31, 2021 | 9.88% |
| Sep 30, 2021 | 5.20% |
| Jun 30, 2021 | -10.07% |